Valère Lounnas

Valère Lounnas
European Molecular Biology Laboratory (Heidelberg) · Theoretical study of proteins and their function

Doctor of Philosophy

About

11
Publications
4,143
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
20
Citations
Citations since 2017
11 Research Items
20 Citations
20172018201920202021202220230246810
20172018201920202021202220230246810
20172018201920202021202220230246810
20172018201920202021202220230246810
Introduction

Publications

Publications (11)
Preprint
Full-text available
CONCLUSIONS The objective was here to present a genome characteristic that may partly explain the sudden propagation of the monkeypox virus in the form we observe in May 2022 in quite a number of countries. The role of the peculiar 30-T base long sequence right in the middle of the virus genome is still to be determined.
Article
Full-text available
.The emergence of the Omicron variant of SARS-CoV2 identified first in South Africa was announced with anxiety in media following alarm and concern by many researchers in the scientific community and the WHO has declared it a variant of concern (VOC): “The discovery of a highly mutated coronavirus variant in South Africa has triggered a global scra...
Article
Full-text available
We analyzed 15 genomes and Spikes of the new OMICRON variant, on the one hand 7 from the very first 21K lineage (South Africa, USA, Belgium, Canada), on the other hand 8 from the later second sister-clade 21L (USA , Switzerland, UK). We applied, at the scale of the whole genome and the spike gene, the biomathematics method of Fibonacci meta-struct...
Chapter
Full-text available
Summary for the hurried reader : in this part 3 of chapter 8, we have deepened the initial work of Li-Meng Yan to demonstrate that she is indisputably right on two crucial issues that demonstrate the artificiality of SARS-Cov2. Firstly, we show that the three viruses : SARS-Cov2 (human), RaTG13 (bat) and Pan-Cov-GD (Pangolin-Cov-2020), supposedly f...
Article
TO THE EDITOR We were surprised by the hydroxychloroquine dose chosen in the Randomized Evaluation of Covid-19 Therapy (RECOVERY) trial conducted by Horby et al. (Nov. 19 issue).1 In this trial, patients received a higher dose of hydroxychloroquine (4 g cumulated over the first 3 days) than that administered in the trial conducted by Lagier et al.2...
Article
Full-text available
Several points of concern arise regarding the methodology and the presented results of Discovery, the large French multicenter, randomized, controlled trial which evaluated the efficacy and safety of lopinavir + ritonavir (L/r), lopinavir/ritonavir + Interferon β-1a (L/r + IFN), and hydroxychloroquine (HCQ) in adults hospitalized for COVID-19. Resu...
Article
Full-text available
France Soir has already published two articles on hydoxychloroquine (HCQ) overdosing during the first day of treatment of patients with Covid-19 acute symptoms in the HCQ arm of the Recovery trial (1, 2). In that trial, a loading dose of 2.4 g was administered at day 1, in 4 separate intakes spread over 24h, followed by 800 mg/day the next 9 days....

Network

Cited By